Table 1.
Demographic characteristics, laboratory data, and prognostic stage of 170 patients with multiple myeloma diagnosed for the first time
| Variable | n (%) or median (IQR * ) |
|---|---|
| Male gender | 86 (50.6%) |
| Age in years (n=156) | 62 (54 – 72) |
| Age in categories | |
| <40 | 4 (2.6%) |
| 40-49 | 15 (9.6%) |
| 50-59 | 48 (30.7%) |
| 60-69 | 38 (24.4%) |
| 70-79 | 39 (25%) |
| ≥80 | 12 (7.7%) |
| Laboratory Exams | |
| Hemoglobin (n=163) | 9.6 (7.9 – 12) |
| Leukocytes (n=163) | 7100 (5080 – 9500) |
| Platelets (n=162) | 234000 (164000 – 315000) |
| Creatinine (n=163) | 1.1 (0.8 – 2.5) |
| Calcium (n=163) | 9.2 (8.4 – 10) |
| Albumin (n=160) | 3 (2.5 – 3.7) |
| β2 microglobulin (n=102) | 5.6 (3.5 – 9.9) |
| Salmon-Durie Staging (n=164) | |
| I II III |
3 (1.8%) 17 (10.4%) 144 (87.8%) |
| ISS Staging (n=102) | |
| I II III |
22 (21.6%) 29 (28.4%) 51 (50%) |
*
Interquartile range